353 filings
Page 10 of 18
8-K
2c70ce0mho15 00
26 Mar 12
Gencarotm’s Norepinephrine Lowering Likely Contributes to Its Effect In Atrial Fibrillation Prevention
12:00am
8-K
57rg120k5t4fozvj
19 Jan 12
Arca Biopharma Announces Additional Patent Issued for Methods for Treatment with Bucindolol Based on Genotype of Patient
12:00am
8-K
qtva4ubhy 02
30 Dec 11
Arca Biopharma Announces Additional Patent Issued for Methods
12:00am
8-K
83iph68b55dh26
22 Dec 11
Arca Biopharma Announces Private Placement of $1.75 Million
12:00am
8-K
ub7l5qwc466qsl
17 Nov 11
Gencarotm Demonstrated 74% Risk Reduction for New Onset
12:00am
8-K
m0dv3
14 Nov 11
Other Events
12:00am
8-K
w6cd3q7v7
24 Jun 11
Other Events
12:00am
8-K
dglwt35m77d 2ilosf
20 Jun 11
Entry into a Material Definitive Agreement
12:00am
8-K
akp3dz3nuxhgni3
26 May 11
Arca Biopharma Announces Planned Expansion of Gencaro
12:00am
8-K
uc6jewo79h hwxqy19v
24 May 11
Termination of a Material Definitive Agreement
12:00am
8-K
tnqyug1c0
23 May 11
Submission of Matters to a Vote of Security Holders
12:00am
8-K
f0ramq
3 May 11
Arca Biopharma Signs Global Rights Agreement with Large
12:00am
8-K
t5va7r86ocaa8716x0
18 Apr 11
Entry into a Material Definitive Agreement
12:00am
8-K
ho4pu
18 Apr 11
Arca Biopharma Announces $3 Million Equity Offering
12:00am
8-K
6i3nv2l5 gil1r5
5 Apr 11
Entry into a Material Definitive Agreement
12:00am
8-K
2xeum1scgb k6j
28 Mar 11
Departure of Directors or Certain Officers
12:00am
8-K
fv36ccy mo
3 Mar 11
Other Events
12:00am
8-K
jw0gfh
17 Feb 11
Departure of Directors or Certain Officers
12:00am
8-K
h5q94
26 Jan 11
Entry into a Material Definitive Agreement
12:00am
8-K
pz6nxv0ksis
18 Jan 11
Other Events
12:00am